Prognostic value of epigenomic profiling in lung cancer

Alok Mishra, Mukesh Verma


Among all types of lung cancers, non-small cell lung cancer (NSCLC) is the most common cause of cancer-associated death. Conventional therapy of NSCLC includes radiation, surgery, and cis-platin therapy. However, other approaches of treatment, including epigenetic therapy, have been proposed (1-4).